GAD65Ab specific anti-idiotypic antibody prevents the onset of type 1 diabetes in NOD mice

被引：0
|
作者：
Wang, X. [1 ]
Hampe, C. S. [2 ]
Yu, J. [1 ]
机构：
[1] TCM, Dept Endocrinol, Jiangsu Prov Hosp, Nanjing, Peoples R China
[2] Univ Washington, Dept Med, Seattle, WA USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
198
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [31] AUTOANTIBODIES AGAINST GAD(65) RATHER THAN GAD(67) PRECEDE THE ONSET OF TYPE-1 DIABETES
    LUHDER, F
    SCHLOSSER, M
    MAUCH, L
    HAUBRUCK, H
    RJASANOWSKI, I
    MICHAELIS, D
    KOHNERT, KD
    ZIEGLER, M
    AUTOIMMUNITY, 1994, 19 (02) : 71 - 80
  • [32] ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (IL-2R MAB) SUPPRESSES INSULITIS IN NOD MICE AND INDUCES ANTI-IDIOTYPIC ANTIBODIES
    PANKEWYCZ, O
    HATTORI, M
    IKEGAMI, H
    EISENBARTH, G
    STROM, TB
    KELLEY, VE
    DIABETES, 1988, 37 (05) : A9 - A9
  • [33] Phototherapy delays onset of type 1 diabetes in autoimmune NOD mice
    Ghoreishi, M.
    Dutz, J. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S200 - S200
  • [34] Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes
    Daka, Bledar
    Svensson, Maria K.
    Lernmark, Ake
    Mincheva-Nilsson, Lucia
    Hallmans, Goran
    Rolandsson, Olov
    AUTOIMMUNITY, 2009, 42 (06) : 507 - 514
  • [35] Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice
    Huebner, Marc P.
    Larson, David
    Torrero, Marina N.
    Mueller, Ellen
    Shi, Yinghui
    Killoran, Kristin E.
    Mitre, Edward
    CLINICAL IMMUNOLOGY, 2011, 141 (02) : 205 - 217
  • [36] Intravenous injection of apoptotic cells prevents type 1 diabetes in NOD mice
    Xia, Chang-Qing
    Annamalai, Mani
    Gordon, David
    Qiu, Yushi
    Peng, Ruihua
    Clare-Salzler, Michael
    DIABETES, 2007, 56 : A319 - A319
  • [37] Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes
    Richardson, Carolyn C.
    McLaughlin, Kerry A.
    Brown, Thomas J.
    Morgan, Diana
    Feltbower, Richard
    Powell, Michael
    Furmaniak, Jadwiga
    Smith, Bernard Rees
    Christie, Michael R.
    AUTOIMMUNITY, 2013, 46 (06) : 375 - 381
  • [38] The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
    Oak, Shilpa
    Gilliam, Lisa K.
    Landin-Olsson, Mona
    Torn, Carina
    Kockum, Ingrid
    Pennington, Christina R.
    Rowley, Merrill J.
    Christie, Michael R.
    Banga, J. Paul
    Hampe, Christiane S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (14) : 5471 - 5476
  • [39] Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations
    Kahara, T
    Takamura, T
    Ando, H
    Sakurai, M
    Ota, T
    Misaki, T
    Oba, S
    Iguchi, M
    Komori, K
    Kobayashi, K
    INTERNAL MEDICINE, 2003, 42 (06) : 517 - 520
  • [40] Anti-GAD 65 antibodies: the link between type 1 diabetes and epilepsy
    Lopez-Sublet, M.
    Reach, G.
    Cohen, R.
    Paulino, C.
    Mourad, J. J.
    Sao, A. Buu
    Ramanoelina, J.
    Krivitzky, A.
    DIABETES & METABOLISM, 2007, 33 : S115 - S115
12345